L Fauchier1, I Robin, A de Labriolle
1Service de cardiologie B et laboratoire d'electrophysiologie cardiaque, centre hospitalier universitaire Trousseau, 37044 Tours, France. lfau@med.univ-tours.fr
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Anticoagulant therapy effectively prevents thromboembolic events in atrial fibrillation but increases bleeding risk. Individualized risk assessment is crucial for optimizing treatment and patient outcomes.
Area of Science:
Context:
Purpose:
Summary:
Impact: